Rates of Serious Infection After Initiation of Ustekinumab or Other Biologics in Patients With Psoriasis or Psoriatic Arthritis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Arthritis Care & Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of Hospitalization for Serious Infection After Initiation of Ustekinumab or Other Biologics in Patients With Psoriasis or Psoriatic Arthritis
Arthritis Care Res (Hoboken) 2022 Nov 01;74(11)1792-1805, Y Jin, H Lee, MP Lee, JE Landon, JF Merola, RJ Desai, SC KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.